C156380Level 4
Trastuzumab/Pertuzumab/Vinorelbine Regimen
**Semantic type:** Therapeutic or Preventive Procedure
**Definition:** A regimen consisting of trastuzumab, pertuzumab, and vinorelbine that may be used as a treatment for recurrent and metastatic HER-2 (EGFR2; ErbB2)-positive advanced or metastatic breast cancer.
**Synonyms:** - Pertuzumab/Trastuzumab/Vinorelbine - Trastuzumab-Pertuzumab-Vinorelbine - Trastuzumab-Pertuzumab-Vinorelbine Regimen - Trastuzumab/Pertuzumab/Vinorelbine - VHP - VHP - VHP (trastuzumab-anns) - VHP (trastuzumab-dkst) - VHP (trastuzumab-dttb) - VHP (trastuzumab-herw) - VHP (trastuzumab-pkrb) - VHP (trastuzumab-qyyp) - VHP (trastuzumab-zerc)
GET
/api/v1/systems/nci_thesaurus/nodes/C156380Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.